Sunshine Biopharma Inc (SBFM) insider trading
Every open-market stock purchase and sale by Sunshine Biopharma Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Steve N. Slilaty (CEO), $10K, 2 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $0.17 on Oct 22, 2026.
Recent SBFM insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Aug 7, 2026 | David Natan (Director) | Bought (not open market) | — |
| Apr 14, 2026 | David Natan (Director) | Bought (not open market) | — |
Who's trading SBFM
- David Natan, Director: other filings, last Aug 7, 2026
Get free alerts when an insider at Sunshine Biopharma Inc files a new trade →